Resources search

Disability considerations for COVID-19 vaccination: WHO and UNICEF policy brief, 19 April 2021

WORLD HEALTH ORGANISATION (WHO)
UNITED NATIONS CHILDREN'S FUND (UNICEF)
Eds
April 2021

Expand view

Persons with disabilities are disproportionately impacted by COVID-19, both directly because of infection, and indirectly because of restrictions to reduce the spread of the virus. Persons with disabilities are a diverse group, and the risks, barriers and impacts faced by them will vary in different contexts according to, among other factors, their age, gender identity, type of disability, ethnicity, sexual orientation, and migration status.

This document presents considerations and actions for the following stakeholders to ensure equity in access to vaccination against COVID‑19 for persons with disabilities:

− Persons with disabilities and their support networks

− Governments

− Health service providers delivering vaccinations

− Organizations of persons with disabilities

− Disability service providers

− Residential institutions and long-term care facilities

− Community

10 health questions about the Caucasus and Central Asia

JAKUBOWSKI, Elke
ARNAUDOVA, Albena
2009

Expand view

This book highlights the essentials of health and health systems in eight countries in the region. It then compares these national data with the average data for three groups - their own, the 15 countries that were members of the European Union (EU) before 1 May 2004 and the 27 current EU Member States. Each chapter provides a concise overview of key health indicators in one of the eight countries, summarises the key features of the country's health system and describes the results of over a decade of health system reform

Benchmarking antiretroviral prices in countries of the former Soviet Union

WANING, Brenda
et al
June 2008

Expand view

This study benchmarks ARV prices of former Soviet Union (FSU) countries against each other and against global and European region ARV prices. The study reveals that extreme price variation exists within and across FSU countries for identical ARVs, which suggests that some countries may be able to obtain ARVs at lower prices and therefore purchase additional ARVs to treat more people

Fight AMR : save medicines for our children : call for action

ECUMENICAL PHARMACEUTICAL NETWORK (EPN)
2008

Expand view

This leaflet has been produced to raise awareness about antimicrobial resistance and possible areas of intervention including infection control, promoting effective diagnosis, improving prescribing practices and encouraging optimal use of antimicrobial agents. It is targeted at all the different groups of stakeholders who are in position to contribute to implementation of the containment actions that have been defined in the WHO Global Strategy for Containment of Antimicrobial Resistance

Women, harm reduction, and HIV

PINKHAM, Sophie
MALINOWSKA-SEMPRUCH, Kasia
September 2007

Expand view

This report looks at factors that reduce women drug users’ access to health care including punitive policies, discrimination by police and health care providers, the intense social stigma attached to drug use by women, a preponderance of harm reduction and drug treatment programmes directed primarily toward men, an absence of sexual and reproductive health services for drug users, and poor access to effective outpatient drug treatment. Pregnant drug users are particularly vulnerable. In too many instances, they receive little or no accurate information about drug use during pregnancy or prevention of mother-to-child transmission of HIV. In some countries pregnant drug users are rejected by health care providers, threatened with criminal penalties or loss of parental rights, or coerced into having an abortion or abandoning their newborns to the state. Poor access to medication-assisted treatment jeopardises the pregnancies of opiate-dependent drug users. It includes recommendations for consideration when designing services for women drug users and also examines issues around policies to protect women's health

2006 report on the global AIDS epidemic

JOINT UNITED NATIONS PROGRAMME ON HIV/AIDS (UNAIDS)
2006

Expand view

This annual report takes an overall look at the global AIDS epidemic. Provides an impact analysis of AIDS on populations at risk and civil society. Looks at effective ways to prevent, control and treat the disease. Indicates how to improve allocation and use of financial resources, design and implement effective national policies and approach the response from a strategic perspective rather than in terms of crisis management. Annexes include country profiles, essential statistics and country progress indicators

Equitable access to essential medicines : a framework for collective action

WORLD HEALTH ORGANIZATION (WHO)
March 2004

Expand view

Equitable and universal access to essential medicines is a vital aspect of any health strategy in resource-limited settings. This document provides a framework of action for policy makers, highlighting the key objectives of successful essential drugs programmes: rational selection and use of essential medicines; affordable prices; sustainable financing; reliable supply systems

2004 report on the global AIDS epidemic

WOODS, Sandra
Ed
2004

Expand view

This annual report takes an overall look at the global AIDS epidemic. It considers the impact of HIV and AIDS on people and societies and includes a particular focus on the orphans and vulnerable children. It takes a further look at scaling up HIV prevention initiatives, with considerations about the threat of HIV to young people. There is a look at treatment, care and support for people living with HIV. It also takes into account the notion of human rights and protection. There are finally some considerations of the financing of responses to the crisis, and the need to coordinate national responses to HIV and AIDS. There is a table fo useful information on country specific estimates and data relating to HIV and AIDS

2004 report on the global AIDS epidemic

WOODS, Sandra
Ed
2004

Expand view

This annual report takes an overall look at the global AIDS epidemic. It considers the impact of HIV and AIDS on people and societies and includes a particular focus on the orphans and vulnerable children. It takes a further look at scaling up HIV prevention initiatives, with considerations about the threat of HIV to young people. There is a look at treatment, care and support for people living with HIV. It also takes into account the notion of human rights and protection. There are finally some considerations of the financing of responses to the crisis, and the need to coordinate national responses to HIV and AIDS. There is a table fo useful information on country specific estimates and data relating to HIV and AIDS

AIDS epidemic update : December 2003

JOINT UNITED NATIONS PRGRAMME ON HIV/AIDS (UNAIDS)
WORLD HEALTH ORGANIZATION (WHO)
2003

Expand view

This report reflects the current knowledge and understanding of the AIDS epidemic. It presents estimates and ranges around the estimates to indicate their level of precision. It includes a special section on stigma and discrimination

Hepatitis B vaccine introduction : lessons learned in advocacy, communication, and training

WITTLETT, Scott
January 2001

Expand view

Hepatitis B is especially dangerous for infants, since they may carry the infection for the rest of their lives without knowing it. Chronic carriers can infect others and are at risk of serious liver disease in later life. However, the hepatitis B vaccine, if provided, helps protect infants against these problems. The vaccine's introduction to developing countries only began in the late 1980s, but many countries still cannot afford to administer the vaccine to all children. This paper summarises the lessons learned about effective advocacy with decision makers, communication with parents and caretakers, and training health staff regarding hepatitis B, gained from over ten years of experience introducing hepatitis B vaccine worldwide. It also includes the WHO 'aide-memoire' on hepatitis B

WHO global strategy for containment of antimicrobial resistance

WORLD HEALTH ORGANIZATION (WHO)
2001

Expand view

This strategy provides a framework of interventions to stimulate the prevention of infection, to slow the emergence of resistance and to reduce the spread of resistant microorganisms, in order to reduce the impact of resistance on health and health care costs, while improving access to existing agents and encouraging the development of new agents

Guide to good prescribing : a practical manual

DE VRIES, T. P. G. M.
et al
1994

Expand view

This book provides step by step guidance to the process of rational prescribing, together with many illustrative examples. It teaches skills that are necessary throughout a clinical career. It is primarily intended for undergraduate medical students who are about to enter the clinical phase of their studies but postgraduate students and practicing doctors may also find it a source of new ideas

Essential medicines monitor (formerly: Essential drugs monitor

Expand view

Aimed at policy makers, prescribers, health educators, administrators and health development organisations, the Essential Drugs Monitor covers national drug policy and the implementation of essential drugs programmes worldwide. Contains regular features on operational research, supply and rational use of drugs, together with reviews of relevant publications
irregular
free

E-bulletin